Analysts Conflicted on These Healthcare Names: Lemaitre Vascular (LMAT), Catalyst Pharma (CPRX) and Nektar Therapeutics (NKTR)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lemaitre Vascular (LMAT – Research Report), ...
Hosted on MSN3h
Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trial
The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
Zacks.com on MSN16h
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue Estimates
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago. These ...
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Dyne Therapeutics (DYN) and Kymera Therapeutics (KYMR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lemaitre Vascular (LMAT – Research Report), Dyne ...
US close: Bargain-hunting drives late rally, as stocks surge
US stocks rallied into the close on Friday despite a subdued start as investors went bargain-hunting before the month-end following a poor February performance on equity markets.